SCHAUMBURG, IL, July 23, 2015 /CNW/ - Catamaran Corporation [NASDAQ:
CTRX, TSX: CCT] announced that Optum completed its acquisition of
Catamaran effective earlier today.
Under the terms of the agreement, all of the shares of Catamaran were
acquired for $61.50 per share in cash, with all Catamaran shares
expected to be delisted from NASDAQ effective as of close of trading
today and from the Toronto Stock Exchange (TSX) shortly.
In connection with the completion of the acquisition, Catamaran repaid
in full and terminated its existing senior credit facilities. On July
23, 2015, Catamaran also delivered an irrevocable notice of redemption
to holders of all of its outstanding 4.75% Senior Notes due 2021 (CUSIP
No. 148887AA0) (the "Notes") and irrevocably deposited with the trustee
for the Notes sufficient funds to fund the redemption in full of the
Notes on August 23, 2015. As a result, Catamaran and the subsidiary
guarantors under the Notes have been released from their respective
obligations under the Notes indenture (subject to certain limited
exceptions), effective as of July 23, 2015.
Catamaran, one of the industry's fastest-growing pharmacy benefits
manager, helps organizations and the communities they serve take
control of prescription drug costs. Managing more than 400 million
prescriptions each year on behalf of 35 million members, our flexible,
holistic solutions improve patient care and empower individuals to take
charge of their health. Processing one in every five prescription
claims in the U.S., Catamaran's skill and scale deliver compelling
financial results and sustainable improvement in the overall health of
members. Catamaran is headquartered in Schaumburg, IL., with multiple
locations in the United States and Canada. For more information, please
visit www.CatamaranRx.com, and for industry news and information follow
Catamaran on Twitter, @CatamaranCorp.
For further information:
Investor and Media Contact:
Tel: (312) 261-7805